Adult Dosing
Kaposi's Sarcoma; cutaneous lesions
- Start 0.1% gel bid
- Gradually may be increased to 34 times daily
- Allow gel to dry for3-5min; avoid occlusive dressing
Pediatric Dosing
- Safety and effectiveness in pediatric patients have not been established
[Outline]
- Photosensitivity may occur with retinoids; avoid exposure to excessive sunlight and ultraviolet light
- Alitretinoin gel could cause fetal harm if significant absorption occurs in a pregnant woman. Advise women of child-bearing potential to avoid becoming pregnant during use
- Do not apply other topical products
- Do not use in patients who requires systemic therapy
- Do not apply gel on or near mucosal surfaces or on healthy skin surrounding lesions
- Do not allow patient to shower, bathe, or swim for at least 3 hrs following application
- Do not use occlusive dressings
Cautions: Use cautiously in
- Concurrent phototherapy
- Exercise extreme caution in women of childbearing age
Pregnancy Category:D
Breastfeeding: Safety unknown; not recommended